Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Lung Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Melanoma 2Hematologic Neoplasms 2Advanced Malignant Solid Neoplasm 2Urinary Bladder Neoplasms 1Syndrome 1Spondylitis, Ankylosing 1Rectal Neoplasms 1Psoriasis 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Lupus Erythematosus, Systemic 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Inflammatory Bowel Diseases 1Hematopoietic and Lymphatic System Neoplasm 1HIV Infections 1Fatigue 1Endometrial Neoplasms 1Dyspnea 1Disease 1Crohn Disease 1Cough 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 9Leucovorin 8Fluorouracil 8Bevacizumab 6Cetuximab 5Specimen Handling 4fludarabine 3Pemetrexed 3Nivolumab 3Magnetic Resonance Spectroscopy 3Cyclophosphamide 3pembrolizumab 2encorafenib 2dehydroftorafur 2aldesleukin 2Laparoscopy 2Irinotecan 2Immunoglobulin G 2Gemcitabine 2Folfox protocol 2Disulfides 2Conversion to Open Surgery 2Cisplatin 2Celecoxib 2Carboplatin 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1temsirolimus 1sapanisertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Educational Status × 30 days × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡